Bank of Montreal and Bank of Nova Scotia (Scotiabank) are two of Canada's "Big Six" banks, yet they offer investors meaningfully different risk-and-return profiles. BMO has built a growing U.S. personal and commercial banking franchise alongside its Canadian operations, while BNS remains the most internationally diversified of the group, with a substantial footprint across Latin America and the Caribbean. This stock comparison is relevant for dividend-focused investors, value-oriented traders, and anyone weighing exposure to Canadian financials against emerging-market growth. Because the two names respond differently to interest rates, credit cycles, and currency moves, examining their relative performance and market positioning can help clarify which setup better matches current conditions. I also checked this using Tickeron’s AI Pattern Search Engine to see how the stocks compare on recent patterns.
Bank of Montreal, founded in 1817 and headquartered in Montreal, operates across Canadian Personal and Commercial Banking, U.S. Personal and Commercial Banking, BMO Wealth Management, and BMO Capital Markets. In recent market activity, BMO has shown resilience, with a year-to-date gain in the mid-30% range and a trailing 12-month return above 40%. Its beta of roughly 0.79 indicates lower volatility than the broader market.
Fundamentals have supported the advance. BMO reported a second-quarter net income increase of about 34% year over year, helped by broad-based revenue growth and improved profitability, and raised its quarterly dividend. Strategically, the bank agreed to sell its transportation and vendor-finance businesses, a move that simplifies its portfolio, and it continues to invest in its U.S. platform. One point of caution is valuation: BMO's price-to-earnings (P/E) ratio, near 19, sits above its long-run historical average, suggesting investors are already pricing in meaningful optimism. From what I see, the steadier North American focus provides some ballast here.
Bank of Nova Scotia, known as Scotiabank and founded in 1832, operates through Canadian Banking, International Banking, Global Wealth Management, and Global Banking and Markets. Its International Banking segment spans Mexico, Peru, Chile, and Colombia — the Pacific Alliance countries — giving BNS a growth profile distinct from its domestic peers. Over recent weeks, the stock has consolidated near multi-year highs, with a one-year return approaching 48% and a year-to-date gain above 30%.
The catalyst behind the re-rating is a turnaround led by CEO Scott Thomson, focused on "margin over growth" — shifting capital toward higher-return lending rather than market-share-driven mortgage volume. BNS reported record quarterly earnings with adjusted earnings per share (EPS) up about 21% year over year, and adjusted ROE of 14.2%, surpassing its medium-term target ahead of plan. Management also expanded its share buyback authorization to 40 million shares. The trade-off is higher beta, near 1.20, and sensitivity to Latin American credit conditions and currency fluctuations. I'm watching this closely as the international exposure adds both opportunity and volatility.
The clearest contrast between the two is geographic exposure and its consequences for risk. BMO's North American focus, strengthened by its U.S. banking operations, provides more predictable earnings but ties performance closely to domestic interest rates and the Canadian housing cycle. BNS offers higher structural growth through emerging-market banking, but that same footprint introduces foreign-exchange risk and political sensitivity.
On momentum, BNS has been the stronger performer, with a steeper one-year rally and a record earnings quarter that validated its turnaround. BMO has advanced steadily but with less dramatic catalysts, relying instead on consistent execution and shareholder returns. Valuation also differs: BMO trades at a higher P/E multiple relative to its history, while BNS, though re-rated, still screens more moderately against its forward earnings trajectory. For income investors, BNS currently offers a higher dividend yield (around 3.5% versus BMO's roughly 2.7%), though that premium reflects the additional risk embedded in its international book.
Based on observable factors — trend consistency, momentum, catalyst visibility, and relative positioning — Tickeron's AI would currently lean toward BNS. The bank's record earnings, early achievement of its ROE target, expanded buyback, and stronger trailing performance give it a more defined and durable catalyst path than BMO's steadier but less differentiated setup. That said, the verdict is probabilistic rather than definitive: BNS's higher beta and emerging-market exposure mean its edge could narrow quickly if credit conditions or currency markets deteriorate. Investors weighing the two should treat BNS as the higher-conviction momentum candidate and BMO as the lower-volatility, North-America-centric alternative.
In my analysis of bank stocks like these, I often turn to Tickeron’s automated tools to cross-check signals across multiple timeframes and strategies. One resource that stands out is the Trending AI Robots section, which highlights bots aligned with current market conditions rather than requiring a manual review of hundreds of options. This helps surface relevant positioning in names like BMO and BNS without sifting through every possibility. It’s a practical way to see how rules-based approaches are adapting right now.
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
I’m a trader and independent researcher. My interest lies at the intersection of financial markets, algorithms, and capital management. I develop data-driven tools and strategies and study algorithmic approaches to market analysis. I help turn complex market data into clear insights and practical systems. I believe technology should support, not replace, investment thinking
The Moving Average Convergence Divergence (MACD) for BMO turned positive on October 15, 2026. Looking at past instances where BMO's MACD turned positive, the stock continued to rise in 31 of 46 cases over the following month. The odds of a continued upward trend are 67%.
The Momentum Indicator moved above the 0 level on October 16, 2026. You may want to consider a long position or call options on BMO as a result. In 40 of 65 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 62%.
BMO moved above its 50-day moving average on October 27, 2026 date and that indicates a change from a downward trend to an upward trend.
The 10-day moving average for BMO crossed bullishly above the 50-day moving average on October 30, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In 8 of 15 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are 53%.
Following a +2.18% 3-day Advance, the price is estimated to grow further. Considering data from situations where BMO advanced for three days, in 206 of 384 cases, the price rose further within the following month. The odds of a continued upward trend are 54%.
The Aroon Indicator entered an Uptrend today. In 173 of 327 cases where BMO Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 53%.
The 10-day RSI Indicator for BMO moved out of overbought territory on October 30, 2026. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 40 similar instances where the indicator moved out of overbought territory. In 18 of the 40 cases, the stock moved lower in the following days. This puts the odds of a move lower at 45%.
The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In 37 of 62 cases where BMO's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are 60%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where BMO declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 56%.
BMO broke above its upper Bollinger Band on October 29, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
The Tickeron SMR rating for this company is 3 (best 1 - 100 worst), indicating very strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is 29 (best 1 - 100 worst), indicating low risk on high returns. The average Profit vs. Risk Rating rating for the industry is 21, placing this stock worse than average.
The Tickeron Price Growth Rating for this company is 43 (best 1 - 100 worst), indicating steady price growth. BMO’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron PE Growth Rating for this company is 58 (best 1 - 100 worst), pointing to average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Valuation Rating of 67 (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.405) is normal, around the industry mean (1.507). P/E Ratio (13.948) is within average values for comparable stocks, (11.753). Projected Growth (PEG Ratio) (1.518) is also within normal values, averaging (2.139). Dividend Yield (0.028) settles around the average of (0.035) among similar stocks. P/S Ratio (4.411) is also within normal values, averaging (3.867).
The Tickeron Seasonality Score of 75 (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
a major bank
Industry MajorBanks